Diagnostic value and clinical significance of anti-carbamylated protein (anti-CarP) antibodies in Egyptian patients with rheumatoid arthritis
Aim of the work: The study was performed to assess the diagnostic potential of anti-carbamylated proteins (anti-CarP) antibodies in Egyptian patients with RA and their relation to clinical manifestations, laboratory findings and radiological damage. Patients and methods: The study involved 90 RA pat...
Main Authors: | , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2020-01-01
|
Series: | Egyptian Rheumatologist |
Online Access: | http://www.sciencedirect.com/science/article/pii/S111011641930050X |
id |
doaj-a37157f748474cd8bc3b413e7cd63769 |
---|---|
record_format |
Article |
spelling |
doaj-a37157f748474cd8bc3b413e7cd637692020-11-25T01:12:20ZengElsevierEgyptian Rheumatologist1110-11642020-01-0142114Diagnostic value and clinical significance of anti-carbamylated protein (anti-CarP) antibodies in Egyptian patients with rheumatoid arthritisSamar R. Mohamed0Nanis O. Neseem1Shereen S. Metwally2Basma A. El-Kady3Rheumatology and Rehabilitation Department, Faculty of Medicine, Mansoura University, EgyptRheumatology and Rehabilitation Department, Faculty of Medicine, Mansoura University, Egypt; Corresponding author.Clinical Pathology and Immunology Department, Faculty of Medicine, Mansoura University, EgyptRheumatology and Rehabilitation Department, Faculty of Medicine, Mansoura University, EgyptAim of the work: The study was performed to assess the diagnostic potential of anti-carbamylated proteins (anti-CarP) antibodies in Egyptian patients with RA and their relation to clinical manifestations, laboratory findings and radiological damage. Patients and methods: The study involved 90 RA patients and 90 matched healthy controls. Disease activity score (DAS28) and health assessment questionnaire (HAQ) were assessed. Plain x-ray hands and feet were performed and assessed by modified Larsen’s score. Laboratory investigations including acute phase reactants, rheumatoid factor (RF), anti-cyclic citrullinated peptide (anti-CCP) and anti-CarP antibodies were estimated. Results: The patients mean age was 42.6 ± 10.4 years (20–60 years), disease duration was 4.3 ± 3.3 years and were 82 females (91.1%) and 8 males (8.9%). The mean DAS28 was 4.9 ± 1.2, HAQ was 1.6 ± 0.7 and Larsen score 33.8 ± 12.2. 29/90 (32.2%) patients were positive for anti-CarP antibodies and were significantly associated with extra-articular manifestations and deformity (p < 0.001), but not with acute phase reactants. Anti-CarP antibodies significantly associated with modified Larsen’s (p < 0.001), but not DAS28 (p = 0.13). The sensitivity and specificity were 32.2% and 96.7% for anti-CarP antibodies, 61.1% and 97.8% for anti-CCP antibodies, 66.7% and 91.1% for RF respectively. 25.7% of anti-CCP negative patients showed anti-CarP positivity, and radiological damage was significantly associated with anti-CarP in them. Conclusion: The sensitivity of anti-CarP antibodies was low in comparison to both RF and anti-CCP; however, they showed high specificity and were detected in anti-CCP negative patients, so they could be useful to test beside anti-CCP and RF. Anti-CarP antibodies may reflect disease radiological damage. Keywords: Anti-carbamylated protein (Anti-CarP) antibodies, Egyptian, Rheumatoid arthritis, DAS28, HAQ, Modified Larsen scorehttp://www.sciencedirect.com/science/article/pii/S111011641930050X |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Samar R. Mohamed Nanis O. Neseem Shereen S. Metwally Basma A. El-Kady |
spellingShingle |
Samar R. Mohamed Nanis O. Neseem Shereen S. Metwally Basma A. El-Kady Diagnostic value and clinical significance of anti-carbamylated protein (anti-CarP) antibodies in Egyptian patients with rheumatoid arthritis Egyptian Rheumatologist |
author_facet |
Samar R. Mohamed Nanis O. Neseem Shereen S. Metwally Basma A. El-Kady |
author_sort |
Samar R. Mohamed |
title |
Diagnostic value and clinical significance of anti-carbamylated protein (anti-CarP) antibodies in Egyptian patients with rheumatoid arthritis |
title_short |
Diagnostic value and clinical significance of anti-carbamylated protein (anti-CarP) antibodies in Egyptian patients with rheumatoid arthritis |
title_full |
Diagnostic value and clinical significance of anti-carbamylated protein (anti-CarP) antibodies in Egyptian patients with rheumatoid arthritis |
title_fullStr |
Diagnostic value and clinical significance of anti-carbamylated protein (anti-CarP) antibodies in Egyptian patients with rheumatoid arthritis |
title_full_unstemmed |
Diagnostic value and clinical significance of anti-carbamylated protein (anti-CarP) antibodies in Egyptian patients with rheumatoid arthritis |
title_sort |
diagnostic value and clinical significance of anti-carbamylated protein (anti-carp) antibodies in egyptian patients with rheumatoid arthritis |
publisher |
Elsevier |
series |
Egyptian Rheumatologist |
issn |
1110-1164 |
publishDate |
2020-01-01 |
description |
Aim of the work: The study was performed to assess the diagnostic potential of anti-carbamylated proteins (anti-CarP) antibodies in Egyptian patients with RA and their relation to clinical manifestations, laboratory findings and radiological damage. Patients and methods: The study involved 90 RA patients and 90 matched healthy controls. Disease activity score (DAS28) and health assessment questionnaire (HAQ) were assessed. Plain x-ray hands and feet were performed and assessed by modified Larsen’s score. Laboratory investigations including acute phase reactants, rheumatoid factor (RF), anti-cyclic citrullinated peptide (anti-CCP) and anti-CarP antibodies were estimated. Results: The patients mean age was 42.6 ± 10.4 years (20–60 years), disease duration was 4.3 ± 3.3 years and were 82 females (91.1%) and 8 males (8.9%). The mean DAS28 was 4.9 ± 1.2, HAQ was 1.6 ± 0.7 and Larsen score 33.8 ± 12.2. 29/90 (32.2%) patients were positive for anti-CarP antibodies and were significantly associated with extra-articular manifestations and deformity (p < 0.001), but not with acute phase reactants. Anti-CarP antibodies significantly associated with modified Larsen’s (p < 0.001), but not DAS28 (p = 0.13). The sensitivity and specificity were 32.2% and 96.7% for anti-CarP antibodies, 61.1% and 97.8% for anti-CCP antibodies, 66.7% and 91.1% for RF respectively. 25.7% of anti-CCP negative patients showed anti-CarP positivity, and radiological damage was significantly associated with anti-CarP in them. Conclusion: The sensitivity of anti-CarP antibodies was low in comparison to both RF and anti-CCP; however, they showed high specificity and were detected in anti-CCP negative patients, so they could be useful to test beside anti-CCP and RF. Anti-CarP antibodies may reflect disease radiological damage. Keywords: Anti-carbamylated protein (Anti-CarP) antibodies, Egyptian, Rheumatoid arthritis, DAS28, HAQ, Modified Larsen score |
url |
http://www.sciencedirect.com/science/article/pii/S111011641930050X |
work_keys_str_mv |
AT samarrmohamed diagnosticvalueandclinicalsignificanceofanticarbamylatedproteinanticarpantibodiesinegyptianpatientswithrheumatoidarthritis AT nanisoneseem diagnosticvalueandclinicalsignificanceofanticarbamylatedproteinanticarpantibodiesinegyptianpatientswithrheumatoidarthritis AT shereensmetwally diagnosticvalueandclinicalsignificanceofanticarbamylatedproteinanticarpantibodiesinegyptianpatientswithrheumatoidarthritis AT basmaaelkady diagnosticvalueandclinicalsignificanceofanticarbamylatedproteinanticarpantibodiesinegyptianpatientswithrheumatoidarthritis |
_version_ |
1725167060968800256 |